BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30355037)

  • 1. Not All Stem Cells Are Created Equal.
    Johnston PV; Duckers HJ; Raval AN; Cook TD; Pepine CJ
    Circ Res; 2018 Sep; 123(8):944-946. PubMed ID: 30355037
    [No Abstract]   [Full Text] [Related]  

  • 2. MY APPROACH to stem cell therapy for heart failure patients: Not all cells are created equally.
    Cingolani E
    Trends Cardiovasc Med; 2019 Aug; 29(6):374. PubMed ID: 30928315
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac regeneration in 2017: Novel paradigms in the fight against heart failure.
    Fernández-Avilés F
    Nat Rev Cardiol; 2018 Jan; 15(2):73-74. PubMed ID: 29336435
    [No Abstract]   [Full Text] [Related]  

  • 4. New era of heart failure therapy in pediatrics: Cardiac stem cell therapy on the start line.
    Sano S; Ishigami S; Sano T
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):845-849. PubMed ID: 31248633
    [No Abstract]   [Full Text] [Related]  

  • 5. Reverse remodelling and myocardial recovery in heart failure.
    Kim GH; Uriel N; Burkhoff D
    Nat Rev Cardiol; 2018 Feb; 15(2):83-96. PubMed ID: 28933783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell therapy for acute myocardial infarction: on the horizon or still a dream?
    Fish KM; Ishikawa K; Hajjar RJ
    Coron Artery Dis; 2018 Mar; 29(2):89-91. PubMed ID: 29140809
    [No Abstract]   [Full Text] [Related]  

  • 7. Can stem cells mend a broken heart?
    Davani S; Deschaseaux F; Chalmers D; Tiberghien P; Kantelip JP
    Cardiovasc Res; 2005 Feb; 65(2):305-16. PubMed ID: 15639469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
    Eisen HJ
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid transcatheter left ventricular reconstruction for the treatment of ischaemic cardiomyopathy.
    Zivelonghi C; Klein P; Swaans MJ; Agostoni P
    EuroIntervention; 2018 Mar; 13(16):1899-1901. PubMed ID: 28966158
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem Cell and Left Ventricular Assist Device Combination Therapy.
    Poglajen G; Gregoric ID; Radovancevic R; Vrtovec B
    Circ Heart Fail; 2019 Feb; 12(2):e005454. PubMed ID: 30759999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy in patients with heart failure.
    Vrtovec B; Poglajen G; Haddad F
    Methodist Debakey Cardiovasc J; 2013; 9(1):6-10. PubMed ID: 23518819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Strategies for Clinical Translation of Repeated Cell Therapy.
    Vrtovec B; Bolli R
    Circ Res; 2019 Mar; 124(5):690-692. PubMed ID: 30817255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of direct intramyocardial autologous stem cell grafting in the sub-acute phase after myocardial infarction.
    Laguna G; DI Stefano S; Maroto L; Fulquet E; Echevarría JR; Revilla A; Urueña N; Sevilla T; Arnold R; Ramos B; Gutiérrez H; Serrador A; San Román JA
    J Cardiovasc Surg (Torino); 2018 Apr; 59(2):259-267. PubMed ID: 29582623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device-induced reverse ventricular remodeling.
    Burkhoff D; Holmes JW; Madigan J; Barbone A; Oz MC
    Prog Cardiovasc Dis; 2000; 43(1):19-26. PubMed ID: 10935554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U; Assmus B; Seeger FH; Honold J; Leistner D; Fichtlscherer S; Schächinger V; Tonn T; Martin H; Dimmeler S; Zeiher AM
    Circ Heart Fail; 2009 Sep; 2(5):417-23. PubMed ID: 19808371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of stem cells: Should we keep the "stem" and skip the "cells"?
    Menasché P
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):345-9. PubMed ID: 27021156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invited commentary.
    Dixon IM
    Ann Thorac Surg; 2009 Dec; 88(6):1921-2. PubMed ID: 19932263
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic approaches for cardiac regeneration and repair.
    Hashimoto H; Olson EN; Bassel-Duby R
    Nat Rev Cardiol; 2018 Oct; 15(10):585-600. PubMed ID: 29872165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy.
    Pincott ES; Ridout D; Brocklesby M; McEwan A; Muthurangu V; Burch M
    J Heart Lung Transplant; 2017 Aug; 36(8):837-844. PubMed ID: 28162930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.